Following the Supreme Court's rejection of gene patents, the U.S. proposes steep cuts to reimbursements for breast cancer-gene tests. That natural human genes cannot be patented was one of the biggest biotechnology stories of 2013 and the effects of …
http://ifttt.com/images/no_image_card.png
0 comments:
Post a Comment